BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 19833415)

  • 21. Treatment, management, and monitoring of established rheumatoid arthritis.
    Bingham CO; Miner MM
    J Fam Pract; 2007 Oct; 56(10 Suppl Rapid):S1-7; quiz S8. PubMed ID: 17949607
    [No Abstract]   [Full Text] [Related]  

  • 22. [Early rheumatoid arthritis--rapid help is double help].
    Aringer M; Leuchten N; Machold KP
    Z Rheumatol; 2007 Dec; 66(8):693-701; quiz 702. PubMed ID: 18034251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unmet needs in rheumatoid arthritis.
    Bykerk V
    J Rheumatol Suppl; 2009 Jun; 82():42-6. PubMed ID: 19509330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Therapy of rheumatoid arthritis (chronic polyarthritis)].
    Villiger PM; Stucki G
    Praxis (Bern 1994); 1996 Sep; 85(37):1102-7. PubMed ID: 8927885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. "5D" Outcome in 52 patients with rheumatoid arthritis surviving 20 years after initial disease modifying antirheumatic drug therapy.
    Capell H; McCarey D; Madhok R; Hampson R
    J Rheumatol; 2002 Oct; 29(10):2099-105. PubMed ID: 12375318
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effects of therapy on functional ability of patients with rheumatoid arthritis].
    Kapidzić-Basić N; Selesković H; Mulić S
    Med Arh; 2007; 61(3):164-8. PubMed ID: 18232281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emerging trends in diagnosis and treatment of rheumatoid arthritis.
    Birch JT; Bhattacharya S
    Prim Care; 2010 Dec; 37(4):779-92, vii. PubMed ID: 21050958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Joint damage progression in patients with rheumatoid arthritis in clinical remission: do biologics perform better than synthetic antirheumatic drugs?
    Ciubotariu E; Gabay C; Finckh A;
    J Rheumatol; 2014 Aug; 41(8):1576-82. PubMed ID: 25028383
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early Diagnosis and Treatment of Rheumatoid Arthritis.
    Littlejohn EA; Monrad SU
    Prim Care; 2018 Jun; 45(2):237-255. PubMed ID: 29759122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The "dirty little secret" exposed in the 2013 EULAR recommendations for rheumatoid arthritis therapy.
    Kissin EY
    Clin Ther; 2014 Jul; 36(7):1114-6. PubMed ID: 24996488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Earlier time to remission predicts sustained clinical remission in early rheumatoid arthritis--results from the Canadian Early Arthritis Cohort (CATCH).
    Kuriya B; Xiong J; Boire G; Haraoui B; Hitchon C; Pope J; Thorne JC; Tin D; Keystone EC; Bykerk V;
    J Rheumatol; 2014 Nov; 41(11):2161-6. PubMed ID: 25274902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The role of the conventional drugs in the treatment of rheumatoid arthritis].
    Fantini F
    Recenti Prog Med; 2003; 94(7-8):330-8. PubMed ID: 12868241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Managing patients with resistant rheumatoid arthritis.
    Madden J
    Nurs Stand; 2008 Jul 2-8; 22(43):51-7; quiz 58. PubMed ID: 18655507
    [TBL] [Abstract][Full Text] [Related]  

  • 34. South African recommendations for the management of rheumatoid arthritis: an algorithm for the standard of care in 2013.
    Hodkinson B; Van Duuren E; Pettipher C; Kalla A;
    S Afr Med J; 2013 Jun; 103(8 Pt 2):576-85. PubMed ID: 23885741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rheumatoid Arthritis.
    Sparks JA
    Ann Intern Med; 2019 Jan; 170(1):ITC1-ITC16. PubMed ID: 30596879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of the selective co-stimulation modulator abatacept following 2 years of treatment in patients with rheumatoid arthritis and an inadequate response to anti-tumour necrosis factor therapy.
    Genovese MC; Schiff M; Luggen M; Becker JC; Aranda R; Teng J; Li T; Schmidely N; Le Bars M; Dougados M
    Ann Rheum Dis; 2008 Apr; 67(4):547-54. PubMed ID: 17921185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: a two-year randomized trial.
    Svensson B; Boonen A; Albertsson K; van der Heijde D; Keller C; Hafström I
    Arthritis Rheum; 2005 Nov; 52(11):3360-70. PubMed ID: 16255010
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progression in early rheumatoid arthritis.
    Combe B
    Best Pract Res Clin Rheumatol; 2009 Feb; 23(1):59-69. PubMed ID: 19233046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Glucocorticoids].
    Tanaka H; Hosono O; Kobayashi H; Yoshikawa N; Matsumiya R
    Nihon Rinsho; 2013 Jul; 71(7):1261-5. PubMed ID: 23961677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early rheumatoid arthritis: strategies for prevention and management.
    Combe B
    Best Pract Res Clin Rheumatol; 2007 Feb; 21(1):27-42. PubMed ID: 17350542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.